{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1111.170",
  "meta" : {
    "versionId" : "10",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Lantana EH Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2023-02-28"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-02-23"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.170",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1111.170"
    }
  ],
  "version" : "20210223",
  "name" : "DihydrocodeineScheduleIIAndIII",
  "title" : "Dihydrocodeine Schedule II and III",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-02-23T01:01:00-05:00",
  "publisher" : "Lantana EH Steward",
  "description" : "This value set includes semantic clinical drugs (SCD) and generic pack (GPCK) RxNorm codes.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to group Schedules II and III Dihydrocodeine medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that identify medications of dihydrocodeine),(Exclusion Criteria: Excludes concepts that represent schedule I, V,  unscheduled, nonprescribable, non-human, and inactive Dihydrocodeine medications.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1234941",
            "display" : "chlorpheniramine maleate 0.4 MG/ML / dihydrocodeine bitartrate 0.6 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution"
          },
          {
            "code" : "1596108",
            "display" : "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
          },
          {
            "code" : "1812164",
            "display" : "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:b7059fef-fe63-45e0-a4b5-236da8060cf3",
    "timestamp" : "2024-06-14T11:18:16-04:00",
    "total" : 2,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1596108",
        "display" : "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1812164",
        "display" : "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
      }
    ]
  }
}
